These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8166034)

  • 1. Community pharmacists help HMO cut drug costs.
    Knowlton CH; Knapp DA
    Am Pharm; 1994 Jan; NS34(1):36-42. PubMed ID: 8166034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies.
    Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL
    Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Kaiser Permanente/USC Patient Consultation Study: change in use and cost of health care services.
    McCombs JS; Liu G; Shi J; Feng W; Cody M; Parker JP; Nichol MB; Hay JW; Johnson KA; Groshen SL; Nye MT
    Am J Health Syst Pharm; 1998 Dec; 55(23):2485-99. PubMed ID: 9853633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical care and health care utilization in an HMO.
    Fischer LR; Defor TA; Cooper S; Scott LM; Boonstra DM; Eelkema MA; Goodman MJ
    Eff Clin Pract; 2002; 5(2):49-57. PubMed ID: 11990212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and cost of drugs in a pharmaceutically decentralized health maintenance organization.
    Hardigan WD; Slywka GW; Eng HJ
    Contemp Pharm Pract; 1980; 3(1):23-30. PubMed ID: 10245109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of clinical pharmacists on drug prescribing in a primary-care clinic.
    Stergachis A; Fors M; Wagner EH; Sims DD; Penna P
    Am J Hosp Pharm; 1987 Mar; 44(3):525-9. PubMed ID: 3565410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacist interventions in a capitated pharmacy benefit contract.
    Knapp KK; Katzman H; Hambright JS; Albrant DH
    Am J Health Syst Pharm; 1998 Jun; 55(11):1141-5. PubMed ID: 9626376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact on drug costs and utilization of a clinical pharmacist in a multisite primary care medical group.
    Walker S; Willey CW
    J Manag Care Pharm; 2004; 10(4):345-54. PubMed ID: 15298532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reduction of Medical Cost through Pharmaceutical Inquiries by Community Pharmacists and Relation with Iyaku Bungyo Rates: A Nationwide Survey on Prescription Inquiries].
    Shikamura Y; Mano Y; Komoda M; Negishi K; Sato T; Miyazaki S
    Yakugaku Zasshi; 2016; 136(9):1263-73. PubMed ID: 27592829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic.
    Forstrom MJ; Ried LD; Stergachis AS; Corliss DA
    DICP; 1990 Mar; 24(3):304-9. PubMed ID: 2316237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
    Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
    Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends of generic substitution in community pharmacies.
    Suh DC
    Pharm World Sci; 1999 Dec; 21(6):260-5. PubMed ID: 10658234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capitation payment for medicaid pharmacy services: impact on non-medicaid prescriptions.
    Lipson DP; Yesalis CE; Kohout FJ; Norwood GJ
    Med Care; 1981 Mar; 19(3):342-53. PubMed ID: 7012466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Documenting outpatient problem intervention activities of pharmacists in an HMO.
    Christensen DB; Campbell WH; Madsen S; Hartzema AG; Nudelman PM
    Med Care; 1981 Jan; 19(1):104-17. PubMed ID: 7464303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.